{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -9.090909, "regularMarketPrice": 1.2, "exchange": "NCM", "shortName": "InVivo Therapeutics Holdings Co", "longName": "InVivo Therapeutics Holdings Corp.", "messageBoardId": "finmb_112935519", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "currency": "USD", "marketState": "PRE", "firstTradeDateMilliseconds": 1289831400000, "priceHint": 4, "fiftyTwoWeekLowChange": 0.39000005, "fiftyTwoWeekLowChangePercent": 0.48148152, "fiftyTwoWeekRange": "0.81 - 13.77", "fiftyTwoWeekHighChange": -12.570001, "fiftyTwoWeekHighChangePercent": -0.9128541, "fiftyTwoWeekLow": 0.81, "fiftyTwoWeekHigh": 13.77, "dividendDate": 1581465600, "earningsTimestamp": 1667854800, "earningsTimestampStart": 1667854800, "earningsTimestampEnd": 1667854800, "trailingAnnualDividendRate": 0.0, "epsTrailingTwelveMonths": -6.58, "epsForward": -10.8, "sharesOutstanding": 2860450, "bookValue": 6.481, "fiftyDayAverage": 1.213, "fiftyDayAverageChange": -0.013000011, "fiftyDayAverageChangePercent": -0.010717239, "twoHundredDayAverage": 2.9456, "twoHundredDayAverageChange": -1.7456, "twoHundredDayAverageChangePercent": -0.5926127, "marketCap": 3614568, "forwardPE": -0.11111111, "priceToBook": 0.18515661, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -0.120000005, "regularMarketTime": 1684180792, "regularMarketDayHigh": 1.34, "regularMarketDayRange": "1.2 - 1.34", "regularMarketDayLow": 1.2, "regularMarketVolume": 18860, "regularMarketPreviousClose": 1.32, "bid": 0.0, "ask": 0.0, "bidSize": 18, "askSize": 12, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 1.32, "averageDailyVolume3Month": 94465, "averageDailyVolume10Day": 23600, "trailingAnnualDividendYield": 0.0, "displayName": "InVivo Therapeutics", "symbol": "NVIV"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "One Kendall Square", "address2": "4th Floor Suite B14402 Building 1400 West", "city": "Cambridge", "state": "MA", "zip": "02139", "country": "United States", "phone": "617 863 5500", "website": "https://www.invivotherapeutics.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Dr. Richard M. Toselli", "age": 64, "title": "Pres, CEO, Chief Medical Officer & Director", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": {"raw": 825204, "fmt": "825.2k", "longFmt": "825,204"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Richard C. Christopher", "age": 52, "title": "CFO & Treasurer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 537816, "fmt": "537.82k", "longFmt": "537,816"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Heather M. Hamel J.D.", "age": 32, "title": "Chief Legal Officer & Gen. Counsel", "yearBorn": 1990, "fiscalYear": 2022, "totalPay": {"raw": 446957, "fmt": "446.96k", "longFmt": "446,957"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Robert S. Langer Jr., Ph.D., Sc.D., SCD", "age": 73, "title": "Co-Founder & Member of Scientific Advisory Board", "yearBorn": 1949, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Joseph Philip Vacanti", "age": 73, "title": "Co-Founder", "yearBorn": 1949, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}